• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 26, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Australian doctors overprescribing flu antivirals

Bioengineer by Bioengineer
May 8, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Australian doctors are prescribing antivirals for people with the flu who may not benefit, putting patients at risk of unnecessary side effects and potentially increasing the risk of antimicrobial resistance to these medications, researchers from the University of Adelaide have found.

The large study, published in BMJ Open, investigated the prescription of antibiotics and antivirals for the management of influenza-like illness among 4.2 million patients from 550 general practices across Australia.

Researchers found antibiotics prescribing for managing suspected cases of influenza declined slightly between 2015 and 2017 in line with recommendations by Australian and international organisations to reduce antibiotic resistance.

But the use of antivirals rose from 20% to 30% in the same period, even though current recommendations state antivirals should usually be prescribed to patients at a higher risk of complications, including those affected by chronic respiratory or cardiac conditions.

Lead author Dr Carla Bernardo from the University of Adelaide’s Discipline of General Practice said the study found patients at low risk of complications are receiving as many antivirals as those with chronic conditions.

“Apart from the elderly, who are more likely to have a chronic condition, the majority of children or adults receive little if any benefit from taking antivirals, the exception being those young people with underlying disease,” Dr Bernardo said.

“It is very likely that most individuals aged under 65 do not need antivirals, although between 20-30% of them received prescriptions for these medications in our study.”

Antiviral medications increase the risk of nausea, vomiting, headache, renal events and psychiatric events.

“Antivirals are recommended for the treatment of influenza for patients with chronic conditions in the community, because they shorten the length of the illness and seem to lessen symptoms and complications, such as pneumonia, bronchitis, sinusitis and ear infection.

Importantly these medications can reduce the likelihood of death by 25% among hospitalised individuals, so anything that risks the effectiveness of these medications is of concern,” Dr Bernardo said.

“It is important to remember that the best way to prevent influenza is having the annual flu vaccine, and behavioural measures, such as staying home, hand-washing or the use of masks. These may be more cost-effective strategies to tackle the transmission of influenza among healthy people than prescribing antivirals just in case.”

“Moreover, the indiscriminate use of antivirals can lead to a virus resistance as it happens with antibiotics.”

###

Media Contact
Dr. Carla Bernardo
[email protected]

Related Journal Article

https://www.adelaide.edu.au/news/news106682.html
http://dx.doi.org/10.1136/bmjopen-2018-026396

Tags: Immunology/Allergies/AsthmaInfectious/Emerging DiseasesMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Non-Apoptotic Caspase-8 Pathway Drives MASH Fibrosis

September 26, 2025

Seoul National University of Science and Technology Develops 3D-Printed Carbon Nanotube Sensors for Advanced Smart Health Monitoring

September 26, 2025

Hormones Shape Brain Structure Across Menstrual Cycle

September 26, 2025

Classifying Malignant Colon Polyps via OCT

September 26, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    79 shares
    Share 32 Tweet 20
  • Physicists Develop Visible Time Crystal for the First Time

    72 shares
    Share 29 Tweet 18
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    55 shares
    Share 22 Tweet 14
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Non-Apoptotic Caspase-8 Pathway Drives MASH Fibrosis

Seoul National University of Science and Technology Develops 3D-Printed Carbon Nanotube Sensors for Advanced Smart Health Monitoring

HIV Reprograms CD4+ T Cells for Latency

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.